A newly presented exploratory cohort analysis showed that individuals who were apolipoprotein (APOE) ϵ4/ϵ4 carriers were significantly more likely to have biomarker results indicating symptomatic or at-risk status for mild cognitive impairment…
ORLANDO — Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy…




